Inductive Bio develops an AI virtual lab for small-molecule drug discovery. Its software and predictive models help medicinal chemists evaluate designs, run large numbers of in-silico experiments, and prioritize compounds with stronger prospects for the wet lab.
The company focuses on developability and ADMET properties that influence whether a molecule can become a useful medicine. By combining human scientific judgment with AI chemistry assistants and partner data, Inductive Bio aims to reduce unnecessary synthesis, shorten optimization cycles, and produce better development candidates.
Partnerships Lead
